Page last updated: 2024-11-02

5-hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone and Osteosarcoma

5-hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone has been researched along with Osteosarcoma in 1 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vansteelandt, M1
Blanchet, E1
Egorov, M1
Petit, F1
Toupet, L1
Bondon, A1
Monteau, F1
Le Bizec, B1
Thomas, OP1
Pouchus, YF1
Le Bot, R1
Grovel, O1

Other Studies

1 other study available for 5-hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone and Osteosarcoma

ArticleYear
Ligerin, an antiproliferative chlorinated sesquiterpenoid from a marine-derived Penicillium strain.
    Journal of natural products, 2013, Feb-22, Volume: 76, Issue:2

    Topics: Antineoplastic Agents; Cyclohexanes; Drug Screening Assays, Antitumor; Estuaries; Fatty Acids, Unsat

2013